semaglutide flow study The trial for kidney outcomes in T2DM halted due to interim results meeting efficacy criteria ✨ FLOW is a RCT comparing injectable semaglutide 1.0 mg with placebo as an adjunct Flow diagram for the selection
Pay in 4 interest-free payments of $6.14 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24

























